Does anyone know if there’s a candidate that doesn’t require two doses?
There're a bunch. The main ones are UofOxford/AstraZeneca AZD1222 and the Chinese CanSinoBio Ad5-nCoV - both currently in phase 3. And there're half a dozen more single dose candidates, but I don't think any of them started trials. The majority are double dose, 2, 3, or even 4 weeks apart.
There're a bunch. The main ones are UofOxford/AstraZeneca AZD1222 and the Chinese CanSinoBio Ad5-nCoV - both currently in phase 3. And there're half a dozen more single dose candidates, but I don't think any of them started trials. The majority are double dose, 2, 3, or even 4 weeks apart.